These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3601233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ, Taylor DA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
    [Abstract] [Full Text] [Related]

  • 4. Agonist/antagonist analgesics and nigrostriatal dopamine metabolism in the rat: evidence for receptor dualism.
    Wood PL, McQuade P, Richard JW, Thakur M.
    Life Sci; 1983 May; 33 Suppl 1():759-62. PubMed ID: 6319927
    [Abstract] [Full Text] [Related]

  • 5. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F, Chrapusta SJ, Egan MF.
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
    Tokuyama S, Ho IK, Yamamoto T.
    Brain Res Bull; 2000 Jul 15; 52(5):363-9. PubMed ID: 10922515
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of butorphanol and its metabolites on the levels of monoamines and their metabolites in the rat brain.
    Niwa M, Nose T, Nozaki M, Tsurumi K, Fujimura H.
    Jpn J Pharmacol; 1985 Dec 15; 39(4):515-28. PubMed ID: 2419614
    [Abstract] [Full Text] [Related]

  • 12. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R, Morali F, Pozzi L, Samanin R.
    Br J Pharmacol; 1990 Aug 15; 100(4):774-8. PubMed ID: 2207499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of mesolimbic dopaminergic projections by beta-endorphin in the rat.
    Iyengar S, Kim HS, Marien MR, McHugh D, Wood PL.
    Neuropharmacology; 1989 Feb 15; 28(2):123-8. PubMed ID: 2524013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dopamine in the basal ganglia and benzodiazepine-induced sedation.
    Brose N, O'Neill RD, Boutelle MG, Fillenz M.
    Neuropharmacology; 1988 Jun 15; 27(6):589-95. PubMed ID: 3419542
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission.
    Piepponen TP, Honkanen A, Kivastik T, Zharkovsky A, Turtia A, Mikkola JA, Ahtee L.
    Pharmacol Biochem Behav; 1999 Jun 15; 63(2):245-52. PubMed ID: 10371653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.